Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AACC Rebrands to the Association for Diagnostics & Laboratory Medicine

By LabMedica International staff writers
Posted on 24 Jul 2023

The American Association for Clinical Chemistry (AACC, Washington, DC, USA) has announced a name change to the Association for Diagnostics & Laboratory Medicine (ADLM, Washington, DC, USA). More...

The American Association for Clinical Chemistry (AACC, Washington, DC, USA) has announced a name change to the Association for Diagnostics & Laboratory Medicine (ADLM, Washington, DC, USA). This change reflects the association's role as advocate and champion for a larger professional community involved in diagnostics and laboratory medicine, and its worldwide influence.

While the AACC has been a professional home for clinical chemists since its inception, its programs have over time appealed to a variety of specialties that operate within or alongside the clinical lab. As of today, the association broadly serves those working in or in cooperation with the clinical laboratory. The transition from AACC to ADLM was approved on April 21 through a member vote, in which over two-thirds majority favored the name change.

ADLM is committed to promoting better health via laboratory medicine. It unites over 70,000 clinical lab professionals, physicians, researchers, and business leaders worldwide. These individuals are engaged in various fields including clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other progressive laboratory sciences. Since 1948, ADLM has been instrumental in promoting the shared interests of the field by fostering programs that encourage scientific collaboration, knowledge, expertise, and innovation.

"I'm proud to say that this change has come about by listening to our members and focusing on the best way to ensure a bright future for our profession," said association president Dr. Shannon Haymond. "This name change does not represent a change of direction for the association. Instead, it more accurately reflects an evolution within the field and the association that has long been underway. As we evolve into this new branding, I'd like to emphasize that the goal of the new brand is to broaden our invitation to collaborate, not narrow it."

Related Links:
AACC 
ADLM 


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.